Unlike their infected partners who received CD4 cell count testing and drugs to prevent opportunistic infections at the study clinic, the uninfected partners may have experienced limited direct benefits from study participation, and consequently may have been less motivated to attend visits. This evidence concerns the gene CD4 and Opportunistic infection.